Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Fresenius Medical Care Expands Serbian Production of Bloodlines

Jan. 25 (Bloomberg) -- Fresenius Medical Care AG, the world’s biggest provider of kidney dialysis, said it has expanded production of bloodlines by a third at its Serbian plant.

The addition will increase output to 12 million sets a year at the factory in Vrsac, northeastern Serbia, the company said in an e-mailed statement. The plant also produces concentrates for dialysis kits.

Fresenius, which operates five dialysis clinics in Serbia, plans to add a second factory in Vrsac in 2014 to double production of bloodlines to 24 million units, the company said.

To contact the reporter on this story: Misha Savic in Belgrade at

To contact the editor responsible for this story: James M. Gomez at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.